The Utility of EEG in Clinical Trials

EEG plays an important role in inclusion/exclusion criteria for safety and efficacy evaluations and as biomarkers in clinical trials. Given the heterogeneity of understanding of the strengths and the limitations of EEG in this context, we provide a brief commentary to inform drug sponsors, contract research organizations, and academic partners on some of the questions to consider.

Read More

EEG – a Frontline Tool for the ED

The role for EEG evaluation and monitoring in the ED is well documented, though … there are challenges to obtaining an EEG recording and having it accurately read in a timely manner.

Read More

Update on the impact of COVID-19 on EEG activity

Reports from Wuhan and Lombardy early in this pandemic indicated that COVID-19 has a significant impact on the brain. In the acute period of SARS-CoV-2 infection, 34.6 % patients were observed to have neurological symptoms including stroke, headache, and seizures. Basic science studies on mechanism of viral entry and vascular involvement have corroborated these observations […]

Read More

Long-Term Video-EEG Studies: EMU vs. In-Home

Patient being fitted with an EEG cap

Long-term EEG studies can take days or weeks to schedule and complete, and studies taking place in the Epilepsy Monitoring Unit (EMU) come with increased risk in today’s circumstances. The COVID-19 pandemic has tightened restrictions in hospitals everywhere. For many patients, (in particular, those who only require scalp EEGs and are not having their antiepileptic […]

Read More

Teleneurology is Helping Rural Hospitals Retain Patients

Telemedicine or telehealth has been described as a path to virtual integrated care and is changing health care delivery in communities across the United States (US). The use of telehealth  in hospitals has grown rapidly from  35% in 2010 to 76% in 2017, connecting  patients to vital health care services with consulting practitioners at a […]

Read More

Home-centered EEG Services in the Time of COVID-19

With patients and potential patients across the country being advised to avoid hospitals and to cancel or delay elective procedures, telemedicine and other remote digital health services are being touted as alternative options. Unfortunately, some specialties are better suited than others for such an approach. And, as a result, some patients may be missing important diagnostic […]

Read More

Resources & Recommendations for Neurodiagnostic Testing During COVID-19

ASET- The Neurodiagnostic Society Recently the American Society for Electrodiagnostic Technologists (ASET) published its recommendations on the appropriate infection control precautions to follow when providing needed diagnostic EEG procedures, assuming the presence of the SARS-CoV-2 virus causing the COVID-19 pandemic. We have a link below to the document. ASET has also made available, in pre-publication, […]

Read More

ACNS Resources for Managing Requests for Neurodiagnostic Testing

Recently, the American Clinical Neurophysiology Society (ACNS) published a series of resources covering technologist safety, equipment cleaning, physician staffing and how to manage orders and requests for neurodiagnostic testing, including inpatient EEGs, elective monitoring of patients in the EMU and outpatient testing such as routine and ambulatory video-EEG studies. CortiCare has New EEG Solutions to […]

Read More

New EEG Solutions for New Challenges

March 2020 New Challenges The COVID-19 pandemic has caused many clinicians and facilities to reassess priorities and the processes for delivering services.  This is clearly true in the healthcare segments that CortiCare serves, namely the evaluation and monitoring of patients suspected or at risk for seizures or other brain function complications from chronic or acute […]

Read More